Funded Health Care Startups in Netherlands
Disclosed round sizes in this Netherlands health care list are strongly outlier-driven: the largest disclosed amount is $74M for ViCentra (Series C) on 202…
Disclosed round sizes in this Netherlands health care list are strongly outlier-driven: the largest disclosed amount is $74M for ViCentra (Series C) on 2021-12-16, which dwarfs the rest of the disclosed rounds where the next-largest figures include $40M (Microsure, 2023-10-04), $37M (VarmX, 2023-05-25), $34M (Xeltis, 2023-02-21), and $17M (Pleco Therapeutics, 2022-09-06). At the same time, the data cluster by time: rounds span 2020-05-18 through 2025-08-12, and the most recent window (2025-02-04 to 2025-08-12) contains multiple mid-to-large raises such as Sirius Medical ($10M, 2025-02-04), Plasmacure ($7M, 2025-07-07), and CardiacBooster ($11M, 2025-08-07).
Stage reporting is another notable pattern. “Series Unknown” appears 11 times (e.g., Speaklee $410K on 2025-08-12; Hy2Care $5M on 2025-05-14), while “undisclosed” appears 6 times (e.g., Vivolta on 2023-10-26; Binqy on 2023-09-26). Geographically, Amsterdam, Noord-Holland shows up repeatedly across years (e.g., Speaklee 2025-08-12; Yoni $3M on 2023-12-14; Founda $15M on 2021-02-24), indicating a recurring city-level concentration within the broader Netherlands footprint.
Most recent rounds
45 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Netherlands health care list, and how does it compare to the rest of the disclosed amounts?
ViCentra’s $74M (Series C) on 2021-12-16 is the only disclosed round above $50M. The next-largest disclosed amounts are much lower, including $40M (Microsure, 2023-10-04), $37M (VarmX, 2023-05-25), $34M (Xeltis, 2023-02-21), and $17M (Pleco Therapeutics, 2022-09-06).
Where does the bulk of activity concentrate by date—are there visible recent clusters?
The list spans 2020-05-18 (GATT Technologies) to 2025-08-12 (Speaklee), with several entries tightening into 2025 H1–H2. In that recent stretch alone, disclosed rounds include Sirius Medical $10M (2025-02-04), Hy2Care $5M (2025-05-14), Plasmacure $7M (2025-07-07), and CardiacBooster $11M (2025-08-07).
Which stage labels dominate, and what share is obscured by missing or unknown reporting?
“Series Unknown” is the most frequent label at 11 entries (for example Speaklee 2025-08-12 $410K; Hy2Care 2025-05-14 $5M; Sirius Medical 2025-02-04 $10M). “undisclosed” appears 6 times (Vivolta on 2023-10-26; Binqy on 2023-09-26; Vitestro on 2023-06-06), so 17 of 45 rows don’t provide a disclosed USD amount.
Are certain cities over-represented compared with other locations in the list?
Amsterdam, Noord-Holland appears repeatedly across multiple years and deal sizes: Speaklee is based in Amsterdam (2025-08-12, $410K), Yoni is listed in Amsterdam (2023-12-14, $3M), and Founda is also in Amsterdam (2021-02-24, $15M). Other recurring hubs exist (e.g., Eindhoven, Noord-Brabant includes Plasmacure 2025-07-07 $7M and Microsure 2023-10-04 $40M), but Amsterdam shows up often enough to stand out within the 45-row sample.
Are there notable outliers besides the single largest round size?
Yes: the smallest disclosed USD amount is $320K for Pal (Pre-Seed) on 2023-09-20, which sits far below most other disclosed rounds, including $380K entries such as AVIGI Therapeutics (2025-04-04, $380K) and ExCulture (2023-12-05, $380K). Separately, reporting outliers matter: multiple rows are “undisclosed” (e.g., Vivolta 2023-10-26; Vitestro 2023-06-06), preventing size-based comparisons for those specific deals.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.